298.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
Madrigal Pharmaceuticals Inc. Stock Analysis and ForecastSkyrocketing investment returns - Autocar Professional
Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financia - GuruFocus
Madrigal Pharmaceuticals, Inc. Announces Second-Quarter 2025 Financial Results Release and Webcast Details - Quiver Quantitative
Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewswire
Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewswire Inc.
Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - Insider Monkey
Madrigal Pharmaceuticals Secures $500 Million Credit Facility to Expand MASH Pipeline - MSN
Madrigal Pharmaceuticals: Strengthened Financial Position and Promising Pipeline Expansion Drive Buy Rating - TipRanks
Madrigal Pharmaceuticals secures $500M credit facility from Blue Owl - MSN
Madrigal Pharmaceuticals: Strategic Financing and Growth Potential Justify Buy Rating - TipRanks
What drives Madrigal Pharmaceuticals Inc. stock priceHigh-velocity gains - Autocar Professional
Is Madrigal Pharmaceuticals Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com
What analysts say about Madrigal Pharmaceuticals Inc. stockSuperior portfolio returns - jammulinksnews.com
Madrigal Pharmaceuticals Secures $500 Million in Senior - GlobeNewswire
Madrigal's $500M Financing: Cementing Leadership in the High-Growth MASH Market - AInvest
Madrigal Pharmaceuticals Secures $500M Credit Facility - TipRanks
Madrigal Pharmaceuticals (MDGL) Secures $500 Million Credit Facility - GuruFocus
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured - GuruFocus
Madrigal secures $500 million credit facility to advance MASH pipeline By Investing.com - Investing.com Nigeria
Madrigal Pharmaceuticals Secures $500 Million Senior Secured Credit Facility to Enhance MASH Pipeline and Support Strategic Expansion - Quiver Quantitative
Citizens JMP reiterates Madrigal stock rating on strong Rezdiffra uptake By Investing.com - Investing.com Canada
10 Most Undervalued Healthcare Stocks to Buy According to Analysts - Insider Monkey
Madrigal Pharmaceuticals shares surge after extended patent protection for MASH therapy - MSN
Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 - MSN
Madrigal gains after Rezdiffra patent win - MSN
MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing Rights - MSN
Madrigal Pharmaceuticals Grants Equity Awards to 30 New Team Members - MSN
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
When (MDGL) Moves Investors should Listen - news.stocktradersdaily.com
Madrigal Pharmaceuticals receives notice of allowance for Rezdiffra patent - TipRanks
Madrigal Pharmaceuticals Surges to 222nd in Daily Rankings with $451 Million Turnover - AInvest
Madrigal Pharmaceuticals: Strong Surge or Overpriced? - StocksToTrade
Madrigal Pharmaceuticals stock price target raised by Oppenheimer on patent news - Investing.com Canada
Madrigal’s Surge: Breakthrough in Liver Treatment? - timothysykes.com
Madrigal Pharmaceuticals Soars: Is It Time to Buy? - StocksToTrade
Madrigal Pharmaceuticals (MDGL) Surges Over 12% in Market Gains - GuruFocus
Madrigal Pharmaceuticals (MDGL) Soars on Rezdiffra Patent Approval - GuruFocus
Madrigal gains after Rezdiffra patent win (MDGL:NASDAQ) - Seeking Alpha
Madrigal stock jumps as patent protection for MASH treatment extended By Investing.com - Investing.com Nigeria
Madrigal stock jumps as patent protection for MASH treatment extended - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):